Adam Koppel's most recent trade in Kailera Therapeutics Inc. was a trade of 16,875,000 Series A-1 Preferred Stock done . Disclosure was reported to the exchange on April 16, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kailera Therapeutics Inc | Adam M. Koppel | Director, Ten Percent Owner | 16 Apr 2026 | 16,875,000 | 0 | - | - | Series A-1 Preferred Stock | ||
| Kailera Therapeutics Inc | Adam M. Koppel | Director, Ten Percent Owner | 16 Apr 2026 | 16,875,000 | 16,875,000 | - | - | Common Stock | ||
| Kailera Therapeutics Inc | Adam M. Koppel | Director, Ten Percent Owner | 16 Apr 2026 | 4,145,768 | 0 | - | - | Series B Preferred Stock | ||
| Kailera Therapeutics Inc | Adam M. Koppel | Director, Ten Percent Owner | 16 Apr 2026 | 4,145,768 | 21,020,768 | - | - | Common Stock | ||
| Kailera Therapeutics Inc | Adam M. Koppel | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 16 Apr 2026 | 1,562,500 | 22,583,268 | - | 16 | 25,000,000 | Common Stock |
| Kailera Therapeutics Inc | Adam M. Koppel | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Apr 2026 | 38,300 | 38,300 | - | - | Stock Option (right to buy) | |
| Foghorn Therapeutics Inc | Adam M. Koppel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 16,000 | 16,000 | - | - | Stock Options (Right to buy) | |
| Cerevel Therapeutics Holdings | Adam M. Koppel | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 10,461 | 13,743 | - | - | Common Stock | |
| Solid Biosciences Inc | Koppel M. Adam | Director, Ten Percent Owner | 11 Jan 2024 | 904,160 | 4,034,582 (8%) | 1% | 5.5 | 5,000,005 | Common Stock | |
| Foghorn Therapeutics Inc | Adam M. Koppel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2023 | 16,000 | 16,000 | - | - | Stock Option (right to buy) | |
| Cerevel Therapeutics Holdings | Adam M. Koppel | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 07 Jun 2023 | 432,627 | 60,199,729 | - | 0 | Common Stock | |
| Cerevel Therapeutics Holdings | Adam M. Koppel | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 13,780 | 13,780 | - | - | Stock Option (Right to Buy) | |
| Cerevel Therapeutics Holdings | Adam M. Koppel | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 3,282 | 3,282 | - | - | Common Stock | |
| Solid Biosciences Inc | Adam M. Koppel | Director, Ten Percent Owner | 06 Jun 2023 | 9,650 | 9,650 | - | - | Director Stock Option (Right to Buy) | ||
| Solid Biosciences Inc | Adam M. Koppel | Director, Ten Percent Owner | 13 Dec 2022 | 9,650 | 9,650 | - | - | Director Stock Option (Right to Buy) | ||
| Solid Biosciences Inc | Adam M. Koppel | Director, Ten Percent Owner | 02 Dec 2022 | 2,666 | 2,666 | - | - | Director Stock Option (Right to Buy) | ||
| Foghorn Therapeutics Inc | Adam M. Koppel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 16,000 | 16,000 | - | - | Stock Options (Right to buy) | |
| Cerevel Therapeutics Holdings | Adam M. Koppel | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 23,459 | 23,459 | - | - | Stock Option (Right to Buy) | |
| Foghorn Therapeutics Inc | Adam M. Koppel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jul 2021 | 12,530 | 12,530 | - | - | Stock Option (right to buy) |